PGD2

Pgd2 is a lipid of Fatty Acyls (FA) class. Pgd2 is associated with abnormalities such as Inflammatory disorder, Pleurisy, Rhinitis, Dehydration and Pneumonia. The involved functions are known as antagonists, fat cell differentiation, Phosphorylation, Process and Gene Expression. Pgd2 often locates in Cell surface, Body tissue, Extracellular, Bone Marrow and Membrane. The associated genes with PGD2 are oxytocin, 1-desamino-(O-Et-Tyr)(2)-, P4HTM gene, PTGS2 gene, PTGDS gene and IL3 gene. The related lipids are 15-deoxyprostaglandin J2, Nonesterified Fatty Acids, Lipopolysaccharides, Steroids and Liposomes. The related experimental models are Knock-out and Rodent Model.

Cross Reference

Introduction

To understand associated biological information of PGD2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with PGD2?

PGD2 is suspected in Asthma, Dehydration, Allergic rhinitis NOS, Rhinitis, Infertility, Pneumonia and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with PGD2

MeSH term MeSH ID Detail
Nasal Polyps D009298 26 associated lipids
Myocardial Infarction D009203 21 associated lipids
Myeloproliferative Disorders D009196 5 associated lipids
Muscular Dystrophy, Animal D009137 5 associated lipids
Multiple Sclerosis D009103 13 associated lipids
Meningoencephalitis D008590 4 associated lipids
Melanoma D008545 69 associated lipids
Mammary Neoplasms, Experimental D008325 67 associated lipids
Lung Neoplasms D008175 171 associated lipids
Lung Diseases D008171 37 associated lipids
Per page 10 20 50 100 | Total 189

PubChem Associated disorders and diseases

What pathways are associated with PGD2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with PGD2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with PGD2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with PGD2?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with PGD2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with PGD2?

Knock-out

Knock-out are used in the study 'Multiple roles of the prostaglandin D2 signaling pathway in reproduction.' (Rossitto M et al., 2015).

Rodent Model

Rodent Model are used in the study 'PKA regulatory IIα subunit is essential for PGD2-mediated resolution of inflammation.' (Kong D et al., 2016).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with PGD2

Download all related citations
Per page 10 20 50 100 | Total 3138
Authors Title Published Journal PubMed Link
Imashuku S et al. Tumor differentiation--application of prostaglandins in the treatment of neuroblastoma. 1985 Prog. Clin. Biol. Res. pmid:2986176
Makino S [Physiological and pharmacological actions of prostaglandins and related substances: inflammation and allergy]. 1985 Nippon Rinsho pmid:2989584
Siegl AM and Daly JW Receptor (norepinephrine), P-site (2',5'-dideoxyadenosine), and calcium-mediated inhibition of prostaglandin and forskolin-activated cyclic AMP-generating systems in human platelets. 1985 J Cyclic Nucleotide Protein Phosphor Res pmid:2991349
Hall TJ et al. Decreased natural killer cell activity in atopic eczema. 1985 Immunology pmid:3876984
Förstermann U et al. Studies on the mechanism of central cardiovascular and temperature responses to prostaglandin D2. 1985 Prostaglandins Leukot Med pmid:2991946
Hamid S and Whittle BJ Interaction of prostaglandin D2 with prostacyclin, carbacyclin and the hydantoin prostaglandin, BW245C, in guinea-pig platelets. 1985 Br. J. Pharmacol. pmid:2992652
Narumiya S and Toda N Different responsiveness of prostaglandin D2-sensitive systems to prostaglandin D2 and its analogues. 1985 Br. J. Pharmacol. pmid:2992661
Bertelé V et al. Refractoriness of platelets to prostaglandins after infusion in rabbits. 1985 J. Lab. Clin. Med. pmid:2997353
Thompson NT and Scrutton MC Intracellular calcium fluxes in human platelets. 1985 Eur. J. Biochem. pmid:3918866
Urade Y et al. Purification and characterization of rat brain prostaglandin D synthetase. 1985 J. Biol. Chem. pmid:3930495
Schick B and Austen KF Pharmacological modulation of activation-secretion of rat serosal mast cells by chymase, an endogenous secretory granule protease. 1985 Immunology pmid:3935569
Fitscha P et al. Platelet sensitivity to antiaggregatory prostaglandins (PGE1,D2,I2) in patients with peripheral vascular disease. 1985 Am. J. Hematol. pmid:3885723
Wong P et al. Diminished sensitivity of platelet aggregation to prostaglandin D2 in patients with myeloproliferative disorders and in patients with acute leukemia. 1985 Nippon Ketsueki Gakkai Zasshi pmid:3890456
Kiyomiya K and Oh-ishi S Involvement of arachidonic acid metabolites in acute inflammation: detection of 6-keto-PGF1 alpha, thromboxane B2 and PGD2 in rat pleurisy induced by phorbol myristate acetate. 1985 Jpn. J. Pharmacol. pmid:3936958
Lewis RA et al. Pharmacologic regulation of mediator generation and release from the murine bone marrow derived mast cell. 1985 Int. Arch. Allergy Appl. Immunol. pmid:2409010
Norman PS et al. Mediator release after allergic and physical nasal challenges. 1985 Int. Arch. Allergy Appl. Immunol. pmid:2409027
Schleimer RP et al. Role of human basophils and mast cells in the pathogenesis of allergic diseases. 1985 J. Allergy Clin. Immunol. pmid:2410478
Lad PM et al. Receptor-specific threshold effects of cyclic AMP are involved in the regulation of enzyme release and superoxide production from human neutrophils. 1985 Biochim. Biophys. Acta pmid:2411298
Robin JL et al. Regulation of mediator release from mouse bone marrow-derived mast cells by glucocorticoids. 1985 J. Immunol. pmid:3161947
Baud L et al. Lipoxygenase products mediate the attachment of rat macrophages to glomeruli in vitro. 1985 Kidney Int. pmid:3927056
Armstrong RA et al. Competitive antagonism at thromboxane receptors in human platelets. 1985 Br. J. Pharmacol. pmid:2580580
Hollingsworth EB and Patrick GA The effects produced by prostaglandin D2 on serotonin turnover and release and tryptophan uptake. 1985 Pharmacol. Biochem. Behav. pmid:2581275
Fox CC et al. Isolation and characterization of human intestinal mucosal mast cells. 1985 J. Immunol. pmid:2582045
Naclerio RM et al. Inflammatory mediators in late antigen-induced rhinitis. 1985 N. Engl. J. Med. pmid:2582257
Westcott JY and Murphy RC Effect of alcohols on arachidonic acid metabolism in murine mastocytoma cells and human polymorphonuclear leukocytes. 1985 Biochim. Biophys. Acta pmid:2982416
Bhattacharya SK et al. Prostaglandin D2 mediated specific increase in rat brain serotonin. 1985 Proc. West. Pharmacol. Soc. pmid:3865228
Walenga RW et al. Re-examination of the assay for plasma prostanoids by solid-phase extraction, and radioimmunoassay. 1985 Prostaglandins Leukot Med pmid:3865240
Okuyama S et al. Redifferentiation of cancer cells: bestatin, estradiol, and prostaglandin D2. 1985 Ann. N. Y. Acad. Sci. pmid:3868328
Okuyama S and Mishina H Principia of cancer therapy. X. Prostaglandin D2 triggers redifferentiation of the bestatin-treated breast cancer cells in vitro. 1985 Sci Rep Res Inst Tohoku Univ Med pmid:3870142
Okuyama S and Mishina H Principia of cancer therapy. XI. Prostaglandin D2 induces redifferentiation of M1 leukemia cells in vitro irrespective of bestatin. 1985 Sci Rep Res Inst Tohoku Univ Med pmid:3870143
Murray JJ et al. Prostaglandin D2 is released during acute allergic bronchospasm in man. 1985 Trans. Assoc. Am. Physicians pmid:3870298
Kasukabe T et al. Specific inhibition by prostaglandin D2 and its metabolites of lysozyme synthesis in mouse macrophage-like cell line, Mm-1. 1985 Biochim. Biophys. Acta pmid:3855662
Narumiya S and Fukushima M delta 12-Prostaglandin J2, an ultimate metabolite of prostaglandin D2 exerting cell growth inhibition. 1985 Biochem. Biophys. Res. Commun. pmid:3857041
Abbate R et al. Decreased number of PGD2 binding sites on platelets from patients with type IIa hyperlipoproteinemia. 1985 Atherosclerosis pmid:3857047
Watanabe K et al. Enzymatic formation of prostaglandin F2 alpha from prostaglandin H2 and D2. Purification and properties of prostaglandin F synthetase from bovine lung. 1985 J. Biol. Chem. pmid:3858278
Gause GE et al. Hemodynamic effects of postpulmonary administration of prostaglandin D2 in fetal animals. 1985 Proc. Soc. Exp. Biol. Med. pmid:3858885
Seregi A et al. The formation and regional distribution of prostaglandins D2 and F2 alpha in the brain of spontaneously convulsing gerbils. 1985 Brain Res. pmid:3859353
Ikai K et al. Effect of ultraviolet irradiation on mast cell-deficient W/Wv mice. 1985 J. Invest. Dermatol. pmid:3859552
Arisawa M et al. Suppressive effect of prostaglandin D2 on prolactin secretion from rat anterior pituitary. 1985 Asia Oceania J Obstet Gynaecol pmid:3860198
Spannhake EW et al. Influence of mediators of anaphylaxis on collateral ventilation and the lung periphery of the dog. 1985 J. Pharmacol. Exp. Ther. pmid:3860642
Rajtar G et al. Prostaglandins and human platelet aggregation. Implications for the anti-aggregating activity of thromboxane-synthase inhibitors. 1985 Biochem. Pharmacol. pmid:3918536
Mendieta CF et al. Biosynthesis of prostaglandins in gingiva of patients with chronic periodontitis. 1985 J. Periodontol. pmid:3919173
Robinson C and Holgate ST Mast cell-dependent inflammatory mediators and their putative role in bronchial asthma. 1985 Clin. Sci. pmid:2981650
Fortini A et al. Heparin does not interfere with prostacyclin and prostaglandin D2 binding to platelets. 1985 Thromb. Res. pmid:3001968
Wasserman SI The mast cell and theophylline in asthma. 1985 Am. J. Med. pmid:3002176
Bushfield M et al. Inhibition of platelet-activating-factor-induced human platelet activation by prostaglandin D2. Differential sensitivity of platelet transduction processes and functional responses to inhibition by cyclic AMP. 1985 Biochem. J. pmid:3002327
Ichikawa A et al. Up-regulation of prostaglandin D2 receptors by agonist binding to beta-adrenoceptors in rabbit platelets. 1985 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:3004152
Pugliese G et al. Hepatic transformation of prostaglandin D2 to a new prostanoid, 9 alpha,11 beta-prostaglandin F2, that inhibits platelet aggregation and constricts blood vessels. 1985 J. Biol. Chem. pmid:3863819
Bhattacharya SK and Parmar SS Prostaglandin D2-induced potentiation of hexobarbitone hypnosis in rats: role of 5-hydroxytryptamine. 1985 J. Pharm. Pharmacol. pmid:2868104
Gay SW and Kosher RA Prostaglandin synthesis during the course of limb cartilage differentiation in vitro. 1985 J Embryol Exp Morphol pmid:3867724